103 related articles for article (PubMed ID: 8095649)
1. Hepatic toxicity of liposomal encapsulated doxorubicin.
Coker RJ; James ND; Stewart JS
Lancet; 1993 Mar; 341(8847):756. PubMed ID: 8095649
[No Abstract] [Full Text] [Related]
2. Fatal hepatic failure with liposomal doxorubicin.
Hengge UR; Brockmeyer NH; Rasshofer R; Goos M
Lancet; 1993 Feb; 341(8841):383-4. PubMed ID: 8094161
[No Abstract] [Full Text] [Related]
3. Liposomal doxorubicin (Doxil).
Porche DJ
J Assoc Nurses AIDS Care; 1996; 7(2):55-9. PubMed ID: 8679968
[No Abstract] [Full Text] [Related]
4. Liposomal doxorubicin for treatment of AIDS-related Kaposi's sarcoma.
Simpson JK; Miller RF; Spittle MF
Clin Oncol (R Coll Radiol); 1993; 5(6):372-4. PubMed ID: 8305358
[TBL] [Abstract][Full Text] [Related]
5. Liposomal doxorubicin in AIDS-related Kaposi's sarcoma.
Hengge UR; Brockmeyer NH; Baumann M; Reimann G; Goos M
Lancet; 1993 Aug; 342(8869):497. PubMed ID: 8102452
[No Abstract] [Full Text] [Related]
6. Liposomal doxorubicin in the treatment of advanced AIDS-related Kaposi sarcoma.
Bogner JR; Kronawitter U; Rolinski B; Truebenbach K; Goebel FD
J Acquir Immune Defic Syndr (1988); 1994 May; 7(5):463-8. PubMed ID: 8158540
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma.
Northfelt DW; Martin FJ; Working P; Volberding PA; Russell J; Newman M; Amantea MA; Kaplan LD
J Clin Pharmacol; 1996 Jan; 36(1):55-63. PubMed ID: 8932544
[TBL] [Abstract][Full Text] [Related]
8. Liposomal doxorubicin: new preparation. Useful in Kaposi's sarcoma.
Prescrire Int; 1998 Jun; 7(35):69-70. PubMed ID: 10342919
[TBL] [Abstract][Full Text] [Related]
9. Psoriasiform pustular eruptions from pegylated-liposomal doxorubicin in AIDS-related Kaposi's sarcoma.
Kreuter A; Gambichler T; Schlottmann R; Altmeyer P; Brockmeyer N
Acta Derm Venereol; 2001; 81(3):224. PubMed ID: 11558892
[No Abstract] [Full Text] [Related]
10. Liposomal doxorubicin (Doxil): an effective new treatment for Kaposi's sarcoma in AIDS.
James ND; Coker RJ; Tomlinson D; Harris JR; Gompels M; Pinching AJ; Stewart JS
Clin Oncol (R Coll Radiol); 1994; 6(5):294-6. PubMed ID: 7530036
[TBL] [Abstract][Full Text] [Related]
11. Liposomal doxorubicin in AIDS-related Kaposi's sarcoma: long-term experiences.
Wagner D; Kern WV; Kern P
Clin Investig; 1994 Jun; 72(6):417-23. PubMed ID: 7950152
[TBL] [Abstract][Full Text] [Related]
12. Misprint of dosage interval for liposomal doxorubicin hydrochloride.
Subach RA; Ruble J
Am J Health Syst Pharm; 1996 Jul; 53(14):1727. PubMed ID: 8827244
[No Abstract] [Full Text] [Related]
13. DOXIL approved for KS.
James JS
AIDS Treat News; 1995 Dec; (no 236):6. PubMed ID: 11363051
[TBL] [Abstract][Full Text] [Related]
14. Liposomal KS drugs approved.
GMHC Treat Issues; 1996 Apr; 10(4):8-9. PubMed ID: 11363710
[TBL] [Abstract][Full Text] [Related]
15. Liposomal chemotherapies.
Smart T
GMHC Treat Issues; 1995; 9(7/8):13. PubMed ID: 11362653
[TBL] [Abstract][Full Text] [Related]
16. DOXIL superior for KS.
Posit Aware; 1995; ():7. PubMed ID: 11362576
[TBL] [Abstract][Full Text] [Related]
17. Cardiotoxicity after liposomal anthracyclines.
Young AM; Dhillon T; Bower M
Lancet Oncol; 2004 Nov; 5(11):654. PubMed ID: 15522651
[No Abstract] [Full Text] [Related]
18. AIDS-related Kaposi's sarcoma: a phase II study of liposomal doxorubicin. The TLC D-99 Study Group.
Cheung TW; Remick SC; Azarnia N; Proper JA; Barrueco JR; Dezube BJ
Clin Cancer Res; 1999 Nov; 5(11):3432-7. PubMed ID: 10589755
[TBL] [Abstract][Full Text] [Related]
19. Doxil offers hope to KS sufferers.
Prescott LM
J Int Assoc Physicians AIDS Care; 1995 Dec; 1(11):43-4. PubMed ID: 11363097
[TBL] [Abstract][Full Text] [Related]
20. Liposomal-entrapped doxorubicin: an active agent in AIDS-related Kaposi's sarcoma.
Harrison M; Tomlinson D; Stewart S
J Clin Oncol; 1995 Apr; 13(4):914-20. PubMed ID: 7707119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]